MichaelJamesMcNamaraMD

Oncology • Cleveland, OH

Gastrointestinal Cancer, Hematologic Oncology, Melanoma

Physician

Join to view full profile

Dr. McNamara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. McNamara's full profile

Already have an account?

Office
9500 Euclid Ave
R35
Cleveland, OH 44195
Phone+1 216-444-5110
Is this information wrong?

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2005 - 2008
UPMC Medical EducationResidency, Internal Medicine, 2001 - 2005
Case Western Reserve University School of MedicineClass of 2001

Certifications & Licensure

OH State Medical License 2008 - 2026
PA State Medical License 2001 - 2008
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma Start of enrollment: 2014 Feb 10
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

3 citations
Adjuvant Therapy After Neoadjuvant Therapy for Esophageal Cancer: Who Needs It?
Siva Raja, Thomas W Rice, Min Lu, Marie E Semple, Eugene H Blackstone, Sudish C Murthy, Usman Ahmad, Michael McNamara, Andrew J Toth, Hemant Ishwaran> ;Annals of Surgery. 2023 Aug 1
Acellular mucin in lymph nodes isolated from treatment-naïve colorectal cancer resections: a clinicopathologic analysis of 16 cases.
James E Lapinski, Alok A Khorana, Lisa Rybicki, Canan Firat, Hwajeong Lee, Kathryn Piotti, Eugene H Lewis 3rd, Michael McNamara, Vikram Deshpande, Jinru Shia, Deepa T ...> ;Virchows Archiv. 2022 Jul 1
13 citations
Esophageal adenocarcinoma: A dire need for early detection and treatment.
Abel Joseph, Siva Raja, Suneel Kamath, Sunguk Jang, Daniela Allende, Mike McNamara, Gregory Videtic, Sudish Murthy, Amit Bhatt> ;Cleveland Clinic Journal of Medicine. 2022 May 2
486 citations
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A Ajani, Thomas A D'Amico, David J Bentrem, Joseph Chao, David Cooke, Carlos Corvera, Prajnan Das, Peter C Enzinger, Thomas Enzler, Paul Fanta, Farhood Farjah, ...> ;Journal of the National Comprehensive Cancer Network. 2022 Feb 1
Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination.
Andrew Tang, Davendra Sohal, Michael J. McNamara, Sudish C. Murthy, Siva Raja> ;Surgical Oncology Clinics of North America. 2020 Aug 12
19 citations
NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8+ T cell responses capable of curing multi-focal cancer.
Joshua M. Walker, Annah S Rolig, Deborah H. Charych, Ute Hoch, Melissa J Kasiewicz, Daniel Rose, Michael J. McNamara, Ian Hilgart-Martiszus, William L. Redmond> ;Journal for Immunotherapy of Cancer. 2020 May 1
611 citations
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A. Ajani, Thomas A. D'Amico, David J. Bentrem, Joseph Chao, Carlos U. Corvera, Prajnan Das, Crystal S. Denlinger, Peter C. Enzinger, Paul T. Fanta, Farhood Farj...> ;Journal of the National Comprehensive Cancer Network. 2019 Jul 1
Targeted Therapy After Brain Radiotherapy for BRAF-Mutated Melanoma With Extensive Ependymal Disease With Prolonged Survival: Case Report and Review of the Literature.
Abu-Gheida, I.,Chao, S.,Murphy, E.,Suh, J.,Stevens, G. H.,Mohammadi, A. M.,McNamara, M.,Yu, J. S.> ;Front Oncol. 2019 Apr 12
70 citations
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.
Lillian D. Sun, Pauline Funchain, Jung Min Song, Patricia Rayman, Charles S. Tannenbaum, Jennifer S. Ko, Michael J. McNamara, C. Marcela Diaz-Montero, Brian R. Gastman> ;Journal for Immunotherapy of Cancer. 2018 May 16
14 citations
Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen
Neil L. Berinstein, Michael McNamara, Ariane Nguyen, James E. Egan, Gregory T. Wolf> ;Oncoimmunology. 2018 Feb 21
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes
Michael J. McNamara, David J. Adelstein, Daniela S. Allende, Joanna Bodmann, Denise I. Ives, Sudish C. Murthy, Daniel P. Raymond, Siva Raja, Cristina P. Rodriguez, Dav...> ;Journal of Gastrointestinal Cancer. 2017 Jun 1
20 citations
Interferon-γ Production by Peripheral Lymphocytes Predicts Survival of Tumor-Bearing Mice Receiving Dual PD-1/CTLA-4 Blockade
Michael McNamara, Ian Hilgart-Martiszus, Diego M. Barragan Echenique, Stefanie N. Linch, Melissa J Kasiewicz, William L. Redmond> ;Cancer Immunology Research. 2016 Aug 1
5 citations
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma...
Michael J. McNamara, Lisa Rybicki, Davendra Sohal, Daniela S. Allende, Gregory M.M. Videtic, Cristina P. Rodriguez, Kevin L. Stephans, Sudish C. Murthy, Siva Raja, Dan...> ;Journal of Gastrointestinal Oncology. 2016 Apr 1
175 citations
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal
Stefanie N. Linch, Michael McNamara, William L. Redmond> ;Frontiers in Oncology. 2015 Feb 16
Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study.
Sohal, D. P.,Shrotriya, S.,Glass, K. T.,Pelley, R. J.,McNamara, M. J.,Estfan, B.,Shapiro, M.,Wey, J.,Chalikonda, S.,Morris-Stiff, G.,Walsh, R. M.,Khorana, A. A.> ;Cancer. 2015 Feb 14
8 citations
Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8+ T cells
Michael McNamara, Melissa J Kasiewicz, Stefanie N. Linch, Christopher Dubay, William L. Redmond> ;Journal for Immunotherapy of Cancer. 2014 Sep 16
4 citations
Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia
Kriti Mittal, Michael J. McNamara, Brian R. Curtis, Keith R. McCrae> ;JRSM Open. 2014 Jun 1
Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials.
Sohal, D. P.,Rice, T. W.,Rybicki, L. A.,Rodriguez, C. P.,Videtic, G. M.,Saxton, J. P.,Murthy, S. C.,Mason, D. P.,Phillips, B. E.,Tubbs, R. R.,Plesec, T.,McNamara, M. J...> ;Dis. Esophagus. 2014 May 23
17 citations
Current Developments in the Management of Locally Advanced Esophageal Cancer
Michael J. McNamara, David J. Adelstein> ;Current Oncology Reports. 2012 Apr 29
9 citations
IL-3 and oncogenic Abl regulate the myeloblast transcriptome by altering mRNA stability.
Jason Ernst, Louis R. Ghanem, Ziv Bar-Joseph, Michael J. McNamara, Jason L. Brown, Richard A. Steinman> ;Plos One. 2009 Oct 15
4 citations
Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
Gershon Y. Locker, Hoeltgen T, L. Kilton, Krauss S, McNamara M, Richard R. Blough, Johnson C> ;Cancer Treatment Reports. 1987 Jul 1
Join now to see all